Lim Kyungjoon, Jackson Kristy L, Burke Sandra L, Head Geoffrey A
Neuropharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Department of Pharmacology, Monash University, Clayton, Victoria, Australia.
PLoS One. 2016 Dec 21;11(12):e0168425. doi: 10.1371/journal.pone.0168425. eCollection 2016.
The surge in arterial pressure during arousal in the waking period is thought to be largely due to activation of the sympathetic nervous system. In this study we compared in SHR the effects of chronic administration of the centrally acting sympatholytic agent rilmenidine with an angiotensin converting enzyme inhibitor perindopril on the rate of rise and power of the surge in mean arterial pressure (MAP) that occurs with arousal associated with the onset of night. Recordings were made using radiotelemetry in 17 adult SHR before and after treatment with rilmenidine (2mg/kg/day), perindopril (1mg/kg/day) or vehicle in the drinking water for 2 weeks. Rilmenidine reduced MAP by 7.2 ± 1.7mmHg while perindopril reduced MAP by 19 ± 3mmHg. Double logistic curve fit analysis showed that the rate and power of increase in systolic pressure during the transition from light to dark was reduced by 50% and 65%, respectively, but had no effect on diastolic pressure. Rilmenidine also reduced blood pressure variability in the autonomic frequency in the active period as assessed by spectral analysis which is consistent with reduction in sympathetic nervous system activity. Perindopril had no effect on the rate or power of the arousal surge in either systolic or diastolic pressure. These results suggest that the arousal induced surge in blood pressure can largely be reduced by an antihypertensive agent that inhibits the sympathetic nervous system and that angiotensin converting enzyme inhibition, while effective in reducing blood pressure, does not alter the rate or power of the surge associated with arousal.
清醒期觉醒时动脉压的升高被认为主要是由于交感神经系统的激活。在本研究中,我们比较了在自发性高血压大鼠(SHR)中,长期给予中枢性抗交感神经药利美尼定与血管紧张素转换酶抑制剂培哚普利,对夜间觉醒时平均动脉压(MAP)升高速率和升高幅度的影响。对17只成年SHR使用无线电遥测技术进行记录,记录在给予利美尼定(2mg/kg/天)、培哚普利(1mg/kg/天)或饮用水中的赋形剂治疗2周前后的情况。利美尼定使MAP降低了7.2±1.7mmHg,而培哚普利使MAP降低了19±3mmHg。双逻辑曲线拟合分析表明,从亮到暗过渡期间收缩压升高的速率和幅度分别降低了50%和65%,但对舒张压没有影响。通过频谱分析评估,利美尼定还降低了活动期自主频率的血压变异性,这与交感神经系统活动的降低一致。培哚普利对收缩压或舒张压的觉醒激增速率或幅度均无影响。这些结果表明,抑制交感神经系统的抗高血压药物可在很大程度上降低觉醒诱导的血压升高,而血管紧张素转换酶抑制虽然能有效降低血压,但不会改变与觉醒相关的血压升高速率或幅度。